Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

September 23, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Errata- FDA Briefing Document for BH110018

Errata- FDA Briefing Document for BH110018, September 23, 2011

  1. Page 16, first bullet, third sentence: delete text “or Propidium Iodide”.
  2. Page 16, second bullet, change the text to read “Determination of lymphocyte content including T-cells, B-cells, and NK-cells of allogeneic donor products using CD3, CD4, CD8, CD19, CD56, and CD14 expression as detected by flow cytometry.”

Page Last Updated: 08/12/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English